GOSS is a biotechnology penny stock without earnings valued based on future earnings potential based on a "pipeline" which is subject to a long timeline of FDA regulation. On the 30 minute chart. price is shown as being in the overvalued area in the upper VWAP band and well above the POC line of the long-range volume profile. The RSI indicator is now...
Gossamer Bio Healthcare Biotechnology USA Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States and is headquartered in San Diego, California. - High volume in stock - Crossed 200 EMA -...
GOSS Company Gossamer Bio, Inc., USA, Industry Biotechnology Market Cap 953.81M EPS next 5Y 31.90%